Table 3 Relative risk of PTDs in association with hsCRP tertiles
From: Serum hsCRP in early pregnancy and preterm delivery in twin gestations: a prospective cohort study
N(%) | Crude RR (95%CI) | Adjusted RR (95%CI) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | Ptrend | Tertile 1 | Tertile 2 | Tertile 3 | Ptrend | ||
hsCRP Median (IQR) | 618(100) | 0.58 (0.31–0.94) | 1.91 (1.61–2.49) | 5.56 (4.16–7.66) | 0.58 (0.31–0.94) | 1.91 (1.61–2.49) | 5.56 (4.16–7.66) | ||
Overall PTD | 302(48.87) | 1(reference) | 1.19 (0.91,1.51) | 1.40** (1.10,1.74) | 0.032 | 1(reference) | 1.23 (0.93,1.56) | 1.42** (1.08,1.78) | 0.047 |
sPTD | 166(26.86) | 1(reference) | 1.18 (0.86,1.55) | 1.36* (1.00,1.75) | 0.148 | 1(reference) | 1.25 (0.90,1.66) | 1.49* (1.08,1.93) | 0.060 |
mPTD | 136(22.01) | 1(reference) | 1.20 (0.84,1.62) | 1.46* (1.07,1.89) | 0.063 | 1(reference) | 1.19 (0.83,1.62) | 1.32 (0.91,1.79) | 0.309 |